Twist Bioscience Corp Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Financial Statements › Balance Sheet › Liabilities › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-11-17
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $400.00K.
- 2025-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $400.00K.
- 2025-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.50M.
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $1.50M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2025-09-30 | $400.00K 10-K · filed 2025-11-17 | |
| 2025-06-30 | $400.00K 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $1.50M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $1.50M 10-Q · filed 2025-02-03 | |
| 2024-06-30 | $3.70M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $3.70M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $3.71M 10-Q · filed 2024-02-02 | |
| 2023-09-30 | $0.00 10-K · filed 2024-11-18 | $3.71M 10-K · filed 2023-11-21 |
| 2023-06-30 | $3.71M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $2.10M 10-K · filed 2023-11-21 | $0.00 10-Q · filed 2023-02-07 |
| 2022-09-30 | $7.19M 10-K · filed 2024-11-18 | $2.10M 10-K · filed 2022-11-28 |
| 2022-06-30 | $3.30M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $5.70M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $7.80M 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $0.00 10-K/A · filed 2023-06-05 |